Stocks have shown better action this week, helping switch IBD's market outlook to "in confirmed uptrend."
That switch came after Wednesday's session, when the S&P 500 delivered a follow-through day.
Still, the follow-through day was on the marginal side. Investors following IBD's CAN SLIM strategy should proceed with caution.
Among the leading stocks that are acting well, one common theme is a rebound off support near the 10-week moving average.
Some of the main indexes are displaying that same behavior, so it's no surprise to also see it among highly rated stocks.
Remember that in a rising market, 10-week pullbacks can provide a
chance to buy a winning stock or add shares to an existing position.
Credit-card networks MasterCard (MA) and Visa (V)
both have executed 10-week rebounds. MasterCard's actually looks a
little better. You prefer to see active turnover in a rebound, and
MasterCard has that, while Visa has rallied in below-average volume.
Longtime leader Priceline.com (PCLN)
also has lifted off support at its 10-week line. Its IBD industry
group, Leisure-Travel Booking, continues to sport a strong ranking,
standing at No. 13 out of 197 groups as of Thursday.
Genesco (GCO)
has staged a 10-week rebound, too. The shoe and hat retailer tried to
clear a 75.65 buy point from a flat base April 17, but it couldn't close
above that level.
The stock then fell back near its 10-week line before jumping Thursday. It now has managed to close above 75.65.
Other leading stocks have at least regained their 10-week lines, even if they haven't lifted above them at this point. Take Lululemon Athletica (LULU), for example.
Lululemon could be working on a new base as it finds 10-week support.
The seller of high-end athletic clothing has been consolidating for
about three weeks.
Wednesday, May 2, 2012
Tuesday, May 1, 2012
U.S. Federal Reserve forecast
Copper rallied Thursday to its highest level in more than two weeks,
fueled by a more optimistic economic outlook from the Federal Reserve
and by strong technical momentum that may drive prices back toward their
2012 highs.
Copper is higher for a third straight day, extending gains from the previous session during which the U.S. Federal Reserve forecast U.S. growth to "remain moderate over coming quarters and then pick up gradually."
The Fed also said it was ready to launch another round of bond buying if the U.S. economy weakens.
Copper prices moved through two lines of technical defense — the 100-day moving average at around $3.72 per pound and the 200-day at $3.76.
Matthew Zeman, head of trading with Kingsview Financial in Chicago, said the market's ability to hold above the 200-day should attract more buyers and again challenge the upper end of this year's trading range near $4.
"We're going to re-challenge the top end of the previous trading range ... just under $4 (per pound)," Zeman said.
July copper jumped 6.60 cents, or 1.8%, to $3.7735 per pound, after dealing between $3.6960 and $3.7845, another high dating back to April 10.
Comex volumes were heavy once again, with over 101,000 lots traded in late New York business, more than 40% above the 30-day average, according to preliminary Thomson Reuters data.
Copper is higher for a third straight day, extending gains from the previous session during which the U.S. Federal Reserve forecast U.S. growth to "remain moderate over coming quarters and then pick up gradually."
The Fed also said it was ready to launch another round of bond buying if the U.S. economy weakens.
Copper prices moved through two lines of technical defense — the 100-day moving average at around $3.72 per pound and the 200-day at $3.76.
Matthew Zeman, head of trading with Kingsview Financial in Chicago, said the market's ability to hold above the 200-day should attract more buyers and again challenge the upper end of this year's trading range near $4.
"We're going to re-challenge the top end of the previous trading range ... just under $4 (per pound)," Zeman said.
July copper jumped 6.60 cents, or 1.8%, to $3.7735 per pound, after dealing between $3.6960 and $3.7845, another high dating back to April 10.
Comex volumes were heavy once again, with over 101,000 lots traded in late New York business, more than 40% above the 30-day average, according to preliminary Thomson Reuters data.
Saturday, April 28, 2012
Expectations and the smallest increase
The Dow Jones industrial average tacked on 0.5%, while the Nasdaq and
S&P 500 each added 0.2%. Turnover was tracking lower across the
board.
As earnings season keeps rolling, a number of leading stocks were making big moves on their quarterly reports.
Texas Capital Bancshares (TCBI) jumped 6% in fast trade, clearing a 36.71 buy point from a square-box base. The regional bank said quarterly EPS climbed 126% to 70 cents, beating views, as sales rose 32% to $102 million. It also scored an upgrade to buy from Sterne Agee.
SolarWinds (SWI) was up 18% in huge turnover after gapping above its 50-day line to an all-time high. The software maker said quarterly EPS grew 43% to 30 cents, topping forecasts and accelerating from a 21% jump in the fourth quarter of 2011. Revenue, including acquisitions, jumped 39% to $59.7 million. SolarWinds has lifted off support at its 10-week moving average.
O'Reilly Automotive (ORLY) was up 5% in strong volume and carved a new high before giving up some gains. The car parts retailer said quarterly EPS gained 37% to $1.14, ahead of estimates, as revenue jumped 11% to $1.5 billion. Its guidance was roughly in line. The stock hit a new high early Thursday, but has given up gains. It's well extended past its last buying range.
On the downside, Nu Skin Enterprises (NUS) shed 8% despite topping views. Before the open, the skin care products firm reported that its Q1 profit climbed 32% to 74 cents a share vs. expectations of 70 cents. Revenue grew 17% to $462 million, also above estimates. But Nu Skin sees Q2 earnings coming in at 79 cents to 83 cents a share, below expectations of 85 cents.
Celgene (CELG) gapped below its 50-day moving average, losing 4% after reporting disappointing Q1 results. The biotech earned $1.08 a share, up 30% from a year ago. But it missed views by a nickel. Sales rose 13% to $1.27 billion, below expectations and the smallest increase in 11 quarters. It was also the fourth straight quarter of sales growth deceleration.
In economic news, pending home sales jumped by a much better-than-expected 4% in March. Economists had expected a 0.5% gain. New jobless claims declined by 1,000 to a seasonally adjusted 388,000 last week, worse than forecasts for 375,000.
As earnings season keeps rolling, a number of leading stocks were making big moves on their quarterly reports.
Texas Capital Bancshares (TCBI) jumped 6% in fast trade, clearing a 36.71 buy point from a square-box base. The regional bank said quarterly EPS climbed 126% to 70 cents, beating views, as sales rose 32% to $102 million. It also scored an upgrade to buy from Sterne Agee.
SolarWinds (SWI) was up 18% in huge turnover after gapping above its 50-day line to an all-time high. The software maker said quarterly EPS grew 43% to 30 cents, topping forecasts and accelerating from a 21% jump in the fourth quarter of 2011. Revenue, including acquisitions, jumped 39% to $59.7 million. SolarWinds has lifted off support at its 10-week moving average.
O'Reilly Automotive (ORLY) was up 5% in strong volume and carved a new high before giving up some gains. The car parts retailer said quarterly EPS gained 37% to $1.14, ahead of estimates, as revenue jumped 11% to $1.5 billion. Its guidance was roughly in line. The stock hit a new high early Thursday, but has given up gains. It's well extended past its last buying range.
On the downside, Nu Skin Enterprises (NUS) shed 8% despite topping views. Before the open, the skin care products firm reported that its Q1 profit climbed 32% to 74 cents a share vs. expectations of 70 cents. Revenue grew 17% to $462 million, also above estimates. But Nu Skin sees Q2 earnings coming in at 79 cents to 83 cents a share, below expectations of 85 cents.
Celgene (CELG) gapped below its 50-day moving average, losing 4% after reporting disappointing Q1 results. The biotech earned $1.08 a share, up 30% from a year ago. But it missed views by a nickel. Sales rose 13% to $1.27 billion, below expectations and the smallest increase in 11 quarters. It was also the fourth straight quarter of sales growth deceleration.
In economic news, pending home sales jumped by a much better-than-expected 4% in March. Economists had expected a 0.5% gain. New jobless claims declined by 1,000 to a seasonally adjusted 388,000 last week, worse than forecasts for 375,000.
Thursday, April 26, 2012
Experiment in economic policy
Investors Business Daily opines that “Big
government threatens our well-being with irresponsible health care
“reform,” higher taxes on entrepreneurs, a tax-filled cap-and-trade
energy bill, a host of new business-strangling regulations and
trillion-dollar deficits as far as the eye can see.” Then they go on to say: “In
late July, economist J.D. Foster of the Heritage Foundation put it
succinctly: ‘This is no longer an experiment in economic policy. The
results are in: Keynesian stimulus does not work.’ This GDP report
doesn’t change that conclusion a bit”.
It is difficult to be more pessimistic than that. However, they do state that we have “stepped back from the abyss.” and that “our only hope going forward is the private economy. Though hindered by massive government intervention in housing, banking and industry, it’s still the most resilient in the world. Given the list of problems they cite, it is difficult to reconcile the optimism and pessimism contained in the piece. I suspect that we will slip back into recession in another quarter or so. I found little reason or justification for their, admittedly muted, optimism.
It is difficult to be more pessimistic than that. However, they do state that we have “stepped back from the abyss.” and that “our only hope going forward is the private economy. Though hindered by massive government intervention in housing, banking and industry, it’s still the most resilient in the world. Given the list of problems they cite, it is difficult to reconcile the optimism and pessimism contained in the piece. I suspect that we will slip back into recession in another quarter or so. I found little reason or justification for their, admittedly muted, optimism.

Sunday, April 22, 2012
The stock cleared
The S&P 500 snapped a two-week losing streak, but the Nasdaq
failed to do the same. Top-rated stocks also showed some mixed action.
Some marquee names further weakened, but a few of them managed gains
amid choppy market conditions.
Apple (AAPL) logged a second straight weekly loss. The stock is now in its first test of its 10-week line since it cleared a cup-with-handle base in January. But its pullback came in heavy trading, which is not ideal.
The bellwether has had a long, steep ascent and has been above its 10-week line since December. Apple reports after the market's close Tuesday.
Apple (AAPL) logged a second straight weekly loss. The stock is now in its first test of its 10-week line since it cleared a cup-with-handle base in January. But its pullback came in heavy trading, which is not ideal.
The bellwether has had a long, steep ascent and has been above its 10-week line since December. Apple reports after the market's close Tuesday.

Thursday, April 19, 2012
Most understand economics only experientially
There are still many that believe that government actions will get us out of our predicament. They won’t. When we come out of this mess, it will be in spite of these actions. They will serve to make the problem worse and cause it to last much longer. Japan has been employing similar stimuli for two decades, and its economy has still has not recovered.
As time passes, it will become apparent to all but the dullards that these interventions were non-helpful and actually harmful. Most understand economics only experientially. Events as discussed in the following post by Rolfe Winkler today are what will continue to surface with the passage of time and provide enough instances for the experiential learners.
Besides being a terrible decision that will cost taxpayers dearly, the article also talks about the unintended consequences of drawing deposits away from smaller, solid banks to the weaker GMAC. The unintended consequence is to weaken the stronger banks.
Monday, April 16, 2012
Overall price inflation was modest
The Fed's April Beige Book was just released.
According to the report, the economy grew at a "moderate to modest" pace, but a rise in gas prices could hurt consumers in the near term.
The last Beige Book released in February showed economic activity growing steadily throughout the country.
A little more on fears of rising energy costs:
According to the report, the economy grew at a "moderate to modest" pace, but a rise in gas prices could hurt consumers in the near term.
The last Beige Book released in February showed economic activity growing steadily throughout the country.
A little more on fears of rising energy costs:
Overall price inflation was modest in
most Districts. However, contacts in the Cleveland, Richmond, Atlanta,
Chicago, Kansas City, and Dallas Districts cited rising transportation
costs due to higher fuel prices. Minneapolis and Dallas noted that
airlines have raised their fares to offset higher fuel costs. Richmond
reported that rising fuel costs were a serious problem for both land and
ocean shippers, while intermodal transportation firms in Dallas said
that they had increased prices in response to higher fuel costs. In
Atlanta, higher transportation costs were passed through to consumers
without much difficulty. In contrast, contacts in Cleveland, Chicago,
and San Francisco said it was difficult to pass through higher costs to
consumers. Input costs for manufacturers in Boston, Cleveland, and
Kansas City rose somewhat, but with little pass-through. Price pressures
have eased somewhat for manufacturing firms in Philadelphia. Higher
prices for construction materials narrowed profit margins for
contractors in Kansas City.
Prepared by the Federal Reserve Bank of Cleveland based on
information collected on or before April 2, 2012. This document
summarizes comments received from business and other
Subscribe to:
Posts (Atom)